NM_000405.5(GM2A):c.*1239dup AND Tay-Sachs disease, variant AB

Germline classification:: Benign (1 submission)
Last evaluated:: Jun 14, 2016
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000347139.5

Allele description [Variation Report for NM_000405.5(GM2A):c.*1239dup]

NM_000405.5(GM2A):c.*1239dup

Gene:

GM2A:ganglioside GM2 activator [Gene - OMIM - HGNC]

Variant type:

Duplication

Cytogenetic location:

5q33.1

Genomic location:

Preferred name:

NM_000405.5(GM2A):c.*1239dup

HGVS:

NC_000005.10:g.151268690dup
NG_009059.1:g.20639dup
NM_000405.5:c.*1239dupMANE SELECT
NM_001167607.3:c.*1050dup
NC_000005.9:g.150648251dup
NM_000405.4:c.*1239dupA

Links:

dbSNP: rs397883774

NCBI 1000 Genomes Browser:

rs397883774

Molecular consequence:

NM_000405.5:c.*1239dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
NM_001167607.3:c.*1050dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]

Condition(s)

Name:: Tay-Sachs disease, variant AB
Synonyms:: Gm2-gangliosidosis, ab variant
Identifiers:: MONDO: MONDO:0010099; MedGen: C0268275; Orphanet: 309246; OMIM: 272750

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000455393	Illumina Laboratory Services, Illumina	criteria provided, single submitter (ICSL Variant Classification 20161018)	Benign (Jun 14, 2016)	germline	clinical testing	ICSL_Variant_Classification_20161018.pdf Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000455393

Illumina Laboratory Services, Illumina

criteria provided, single submitter

(ICSL Variant Classification 20161018)

Benign
(Jun 14, 2016)

germline

clinical testing

ICSL_Variant_Classification_20161018.pdf

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000455393.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Apr 9, 2023

ClinVar

Relating variation to medicine